KX-826 30 ML SOLUTION

KX-826

KX-826, also known as pyrilutamide, is a nonsteroidal androgen receptor antagonist developed for research involving androgen signaling, hair follicle biology, and androgen-related hair loss.

The compound is designed to bind locally to androgen receptors and reduce the effects of androgens such as dihydrotestosterone at the receptor level. Unlike medications that reduce systemic androgen production, KX-826 is being investigated for its potential to act primarily at the site of application.

KX-826 has been evaluated in clinical studies involving male and female androgenetic alopecia. Research has focused on safety, tolerability, pharmacokinetics, hair-count changes, and the compound’s potential effects on androgen-mediated follicular miniaturization.

Research Areas

• Androgen receptor antagonism
• Androgenetic alopecia research
• Dihydrotestosterone signaling
• Hair follicle miniaturization
• Hair growth-cycle research
• Localized antiandrogen activity

Additional Information

Chemical name: Pyrilutamide
Development code: KX-826
Compound class: Nonsteroidal androgen receptor antagonist
Research status: Investigational

For laboratory and research purposes only. Not intended for human consumption or therapeutic use. This product has not been approved by the FDA to diagnose, treat, cure, or prevent any disease.